We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GRMN:NYSEGarmin Ltd. Analysis

Data as of 2026-05-21 - not real-time

$237.47

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Garmin delivered a record first‑quarter, posting 14% year‑on‑year revenue growth to $1.75 billion and beating EPS expectations by 14%. Margins remain robust with a gross margin near 59% and operating margin above 24%, while the forward PE of 23 suggests earnings momentum outpacing the broader industry (PE ≈ 38). The stock trades at a trailing PE of 26.5, below the industry average, and offers a 1.77% dividend with a 40% payout ratio, indicating sustainable income. Technically, the price of $237.47 sits below the 20‑day and 50‑day SMAs (≈ 242 and 244) and the MACD is in a bearish crossover, though the RSI of 46.6 signals no extreme overbought/oversold condition.
Volatility is elevated at roughly 30% over the past 30 days and beta exceeds 1, pointing to higher systematic risk, yet the stock benefits from stable volume and a solid cash position. Analyst consensus targets imply modest upside (~10%) and the company’s diversified portfolio—from fitness wearables to aviation avionics—provides a defensive cushion, supporting a longer‑term bullish stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Recent earnings beat but price below short‑term moving averages
  • Bearish MACD signal and elevated short‑term volatility
  • Proximity to support level around $224.5

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained 14% revenue growth driven by a 42% surge in the fitness segment
  • Improving earnings outlook with forward PE of 23 and analyst upside
  • Solid cash generation and manageable debt supporting reinvestment

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified product mix across consumer and industrial markets
  • Consistent dividend with a payout ratio under 50% and strong ROE
  • Strategic positioning in high‑growth wearables and aviation avionics

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin23.26%
P/E Ratio26.5
ROE19.90%
ROA11.90%
Debt/Equity2.33
P/B Ratio4.9
Op. Cash Flow$1.7B
Free Cash Flow$810.2M
Industry P/E38.8

Technical Analysis

TrendNeutral
RSI46.6
Support$224.54
Resistance$269.16
MA 20$241.73
MA 50$244.13
MA 200$228.42
MACDBearish
VolumeStable
Fear & Greed Index90.29

Valuation

Fair Value$110.16
Target Price$261.71
Upside/Downside10.21%
GradeFair
TypeBlend
Dividend Yield1.77%

Risk Assessment

Beta1.33
Volatility30.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.